Oxford based IPS open their new US offices to support the expanding East Coast portfolio of pharma clients.
Over the last two years IPS’s digital ecosystems have provided Boston based pharma companies with unique approaches to engaging HCPs and conducting global research. CEO and Founder Peter Ward said “This is an exciting development in IPS’s growth. We see the US as a priority market for us to expand in, to achieve our business vision to be the leading company providing digital engagement solutions for the rare diseases sector”
Stay up to date with all the latest information from Interactive Pharma Solutions by signing up to our mailing list. All the latest information sent directly to your inbox.
All Rights Reserved | Copyright Interactive Pharma Solutions Ltd - Registered in England No. 09245216 - Oxford